Introduction tions, again common to both CD and UC, may include fatigue, anemia and
hypercoagulability. Unlike UC, in which the intestinal inflammation is usually continuous and …

Biologic therapy has changed and will continue to transform the way we treat patients with
Crohn's disease. Treatment success has been redefined. The challenges will be to utilize …

Crohn's disease (CD) is a chronic relapsing and remitting disorder of the gastrointestinal
tract with no known cure. The inflammation that drives the disease can lead to debilitating …

Biologic therapy for Crohn’s disease over the last 3 decades - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Crohn's disease is a chronic gastrointestinal inflammatory disorder, characterized by
episodes of relapsing and remitting flares. As the disease mechanism becomes better …

Introduction Crohn's disease (CD) is a chronic inflammatory bowel disease characterized by
unpredictable flare-ups and periods of remission. While several therapeutic options, such as …

Different classes of biologics are comparable with regards to safety and almost similar in
effectiveness in the management of CD. There are certain clinical scenarios in which one …

Crohn's Disease (CD) and ulcerative colitis (UC) are inflammatory bowel conditions
characterized by abdominal pain, changes in bowel habits, and rectal bleeding. Whereas …

Therapy for Crohn's disease (CD) is evolving at breakneck speed. Biologic therapies are
assuming ever more important roles in treating this unrelenting, life-long disorder. New …

The emergency of effective biological therapy in the treatment of Crohn's disease (CD) has
led to a clinical debate about 'step-up versus top-down strategy'. Step-up refers to the classic …